Plus: treating the whole patient; noninsulin adherence; can Dalcetrapib reduce new-onset diabetes?
May 26, 2020 : DCMS #503 DISASTERS AVERTED — Near Miss Case Studies
Treating the Whole Patient |
|
Letter from the Editor
Over the past 5 years all of the SGLT-2 inhibitors have gotten various indications for cardiovascular protection. Now it appears that a drug used for Acute Coronary Syndrome can have very positive benefits in preventing and reversing diabetes. Check out this week's feature from Chardae Whitner, 2020 PharmD. Candidate, Lake Erie College of Osteopathic Medicine, on the use of dalcetrapib and its effects on diabetes.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief |
|
|
Doctor's Option lab test products include rapid tests and CLIA certified fingerstick lab tests.
Rapid tests offer immediate test results to provide doctors with point of care test results in as little as 90 seconds.
Fingerstick lab tests provide CLIA certified lab accurate results. Each fingerstick lab test collection kit comes with a prepaid postage return envelope and everything you need to obtain and collect your fingerstick blood sample in a 510K FDA approved device.
Fingerstick lab tests are great for people who want to monitor their blood sugar, cholesterol, lipids and other important bio-markers at home or on the go.
Visit Doctor's Option |
|
|
|
|
DISASTERS AVERTED — Near Miss Case Studies |
|
| Treating the Whole Patient
We were running a clinical study on erectile dysfunction. A 68-year-old male with obesity came in looking for help for his ED, so he thought he might qualify for the study. He had not had a medical workup for some time and wasn't aware of any underlying diseases. I recommended he be screened for diabetes.... |
| |
|
|
TOP STORIES - Diabetes News and Research |
|
| |
|
|
|
| | | | About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control. |
| Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
810 Bear Tavern Road Suite 102
Ewing, NJ, 08628
USA
www.diabetesincontrol.com |
|
|
|
|
| | |
|
|
|
|
